Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
Clinical trial NCT02873442 · UNKNOWN
Trial details
- NCT number
- NCT02873442
- Sponsor
- Ningbo Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2018-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.